Show simple item record

dc.contributor.authorMelvær, Giil Lasse
dc.contributor.authorAarsland, Dag
dc.contributor.authorVik-Mo, Audun Osland
dc.date.accessioned2022-02-21T14:08:39Z
dc.date.available2022-02-21T14:08:39Z
dc.date.created2022-01-27T11:10:07Z
dc.date.issued2021
dc.identifier.issn2352-8729
dc.identifier.urihttps://hdl.handle.net/11250/2980580
dc.description.abstractIntroduction Neuropsychiatric symptoms (NPS) in dementia are associated with poor cognitive outcomes in longitudinal studies. Whether this is due to differences in symptom burden between persons (BP) or changes within persons (WP) is unknown. Methods Patients with mild Alzheimer's disease (AD, n = 111) and Lewy-body dementia (LBD, n = 85) were assessed annually for 8 years. We modelled the association between NPS assessed by the Neuropsychiatric Inventory (NPI) and Mini-Mental State Examinations (MMSE) using Tobit mixed-effects model with NPS as individual means over time (BP) and its deviance (WP). Results The association between higher NPS and poorer cognitive outcomes was mostly due to BP differences for the NPI-total score, and in particular for delusions, hallucinations, agitation, aberrant motor behavior, and apathy scores. Discussion The NPS trait (BP) effect on cognitive decline is considerably stronger than the state effect (WP). Clinically, long-term rather than episodic NPS better identifies patients with poor cognitive outcomes.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleDifferentiating traits and states identifies the importance of chronic neuropsychiatric symptoms for cognitive prognosis in mild dementiaen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 The Authorsen_US
dc.source.articlenumbere12152en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1002/dad2.12152
dc.identifier.cristin1991120
dc.source.journalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoringen_US
dc.identifier.citationAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 2021, 13 (1), e12152.en_US
dc.source.volume13en_US
dc.source.issue1en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal